Prague Med. Rep. 2020, 121, 262-266
https://doi.org/10.14712/23362936.2020.23
A Severe Case of Anaplastic Large Cell Lymphoma in a Previously Healthy Woman: Diagnostic and Therapeutic Challenges
References
1. , B. A., Fessele, K. L. (1998) Non-Hodgkin’s lymphoma. Semin. Oncol. Nurs. 14, 273–283.
<https://doi.org/10.1016/S0749-2081(98)80005-3>
2. , B., Pileri, S., Zinzani, P. L., Carbone, A., Zagonel, V., Wolf-Peeters, C., Verhoef, G., Menestrina, F., Todeschini, G., Paulli, M., Lazzarino, M., Giardini, R., Aiello, A., Foss, H. D., Araujo, I., Fizzotti, M., Pelicci, P. G., Flenghi, L., Martelli, M. F., Santucci, A. (1999) ALK+ lymphoma: Clinico-pathological findings and outcome. Blood 93, 2697–2706.
3. , G., Savage, K. J. (2015) The biology and management of systemic anaplastic large cell lymphoma. Blood 126, 17–25.
<https://doi.org/10.1182/blood-2014-10-567461>
4. , S., O’Connor, O. A., Pro, B., Illidge, T., Fanale, M., Advani, R., Bartlett, N. L., Christensen, J. H., Morschhauser, F., Domingo-Domenech, E., Rossi, G., Kim, W. S., Feldman, T., Lennard, A., Belada, D., Illes, A., Tobinai, K., Tsukasaki, K., Yeh, S. P., Shustov, A., Huttmann, A., Savage, K. J., Yuen, S., Iyer, S., Zinzani, P. L., Hua, Z., Little, M., Rao, S., Woolery, J., Manley, T., Trumper, L., Group, E.-S. (2019) Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): A global, double-blind, randomised, phase 3 trial. Lancet 393, 229–240.
<https://doi.org/10.1016/S0140-6736(18)32984-2>
5. , L. M., Wang, S. S., Devesa, S. S., Hartge, P., Weisenburger, D. D., Linet, M. S. (2006) Lymphoma incidence patterns by WHO subtype in the United States, 1992–2001. Blood 107, 265–276.
<https://doi.org/10.1182/blood-2005-06-2508>
6. , M. B., Sundstrom, J. B., Mosunjac, M. I. (2008) Unusual presentation of anaplastic large cell lymphoma with clinical course mimicking fever of unknown origin and sepsis: autopsy study of five cases. Croat. Med. J. 49, 660–668.
<https://doi.org/10.3325/cmj.2008.5.660>
7. , M. A. (2015) Glucocorticoids and cancer. Adv. Exp. Med. Biol. 872, 315–333.
<https://doi.org/10.1007/978-1-4939-2895-8_14>
8. , K. J., Harris, N. L., Vose, J. M., Ullrich, F., Jaffe, E. S., Connors, J. M., Rimsza, L., Pileri, S. A., Chhanabhai, M., Gascoyne, R. D., Armitage, J. O., Weisenburger, D. D.; International Peripheral T-Cell Lymphoma Project (2008) ALK– anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: Report from the International Peripheral T-Cell Lymphoma Project. Blood 111, 5496–5504.
<https://doi.org/10.1182/blood-2008-01-134270>
9. , A., Soma, L. (2019) Anaplastic large cell lymphoma: Contemporary concepts and optimal management. Cancer Treat. Res. 176, 127–144.
<https://doi.org/10.1007/978-3-319-99716-2_6>
10. , D., Fournier, M., Briere, J., Lamant, L., Haioun, C., Coiffier, B., Bologna, S., Morel, P., Gabarre, J., Hermine, O., Sonet, A., Gisselbrecht, C., Delsol, G., Gaulard, P., Tilly, H. (2012) Long-term outcome of adults with systemic anaplastic large-cell lymphoma treated within the Groupe d’Etude des Lymphomes de l’Adulte trials. J. Clin. Oncol. 30, 3939–3946.
<https://doi.org/10.1200/JCO.2012.42.2345>
11. Swerdlow, S. H., Campo, E., Harris, N. L., Jaffe, E. S., Pileri, S. A., Stein, H. (2008) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon.
12. , E. J., Patel, K., Prouet, P., Martin, M. G. (2017) Proliferation through activation: Hemophagocytic lymphohistiocytosis in hematologic malignancy. Blood Adv. 1, 779–791.
<https://doi.org/10.1182/bloodadvances.2017005561>
13. , W., Hu, K., Xu, F., Zhou, D., He, J., Shi, J., Luo, Y., Zhu, J., Zhang, J., Lin, M., Ye, X., Huang, H., Cai, Z. (2013) Clinical analysis and prognostic significance of lymphoma-associated hemophagocytosis in peripheral T cell lymphoma. Ann. Hematol. 92, 481–486.
<https://doi.org/10.1007/s00277-012-1644-6>
